{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:12:35Z","timestamp":1784614355299,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,20]]},"DOI":"10.7759\/cureus.64987","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T13:25:46Z","timestamp":1721481946000},"source":"Crossref","is-referenced-by-count":7,"title":["What Makes It Tick: Exploring the Mechanisms of Post-treatment Lyme Disease Syndrome"],"prefix":"10.7759","author":[{"given":"Kate E","family":"Wester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca C","family":"Nwokeabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehana","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Dunphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Osondu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carson","family":"Wonders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misbahuddin","family":"Khaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-012194851-1\/50040-8","article-title":"Antigenic variation in Borrelia: relapsing fever and Lyme borreliosis","author":"Barbour AG","year":"2003","unstructured":"Barbour AG. Antigenic variation in Borrelia: relapsing fever and Lyme borreliosis. Antigenic variation. Craig A, Scherf A (ed): Academic Press, Cambridge, MA; 2003. 319-56. 10.1016\/B978-012194851-1\/50040-8"},{"key":"ref2","article-title":"Clinical manifestations of Lyme disease in adults","author":"Hu L","year":"2024","unstructured":"Hu L. Clinical manifestations of Lyme disease in adults. UpToDate. Post TW (ed): UpToDate, Waltham, MA; 2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2022.03.004","article-title":"Epidemiology of Lyme disease","volume":"36","author":"Mead P","year":"2022","unstructured":"Mead P. Epidemiology of Lyme disease. Infect Dis Clin North Am. 2022, 36:495-521. 10.1016\/j.idc.2022.03.004","journal-title":"Infect Dis Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/9780470933961","article-title":"Lyme Borreliosis in Europe and North America: epidemiology and clinical practice","year":"2011","unstructured":"Lyme Borreliosis in Europe and North America. epidemiology and clinical practice. Sood SK (ed): Wiley-Blackwell, Hoboken, NJ; 2011. 10.1002\/9780470933961"},{"key":"ref5","article-title":"Treatment of Lyme disease","author":"Hu L","year":"2024","unstructured":"Hu L, Shapiro ED. Treatment of Lyme disease. UpToDate. Post TW (ed): UpToDate, Waltham, MA; 2024."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43112","article-title":"Lyme disease and post-treatment Lyme disease syndrome: current and developing treatment options","volume":"15","author":"Talbot NC","year":"2023","unstructured":"Talbot NC, Spillers NJ, Luther P, et al.. Lyme disease and post-treatment Lyme disease syndrome: current and developing treatment options. Cureus. 2023, 15:e43112. 10.7759\/cureus.43112","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-6681-9","article-title":"Estimation of cumulative number of post-treatment Lyme disease cases in the US, 2016 and 2020","volume":"19","author":"DeLong A","year":"2019","unstructured":"DeLong A, Hsu M, Kotsoris H. Estimation of cumulative number of post-treatment Lyme disease cases in the US, 2016 and 2020. BMC Public Health. 2019, 19:352. 10.1186\/s12889-019-6681-9","journal-title":"BMC Public Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00057","article-title":"Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease","volume":"7","author":"Rebman AW","year":"2020","unstructured":"Rebman AW, Aucott JN. Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease. Front Med (Lausanne). 2020, 7:57. 10.3389\/fmed.2020.00057","journal-title":"Front Med (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01634","article-title":"Robust B cell responses predict rapid resolution of Lyme disease","volume":"9","author":"Blum LK","year":"2018","unstructured":"Blum LK, Adamska JZ, Martin DS, et al.. Robust B cell responses predict rapid resolution of Lyme disease. Front Immunol. 2018, 9:1634. 10.3389\/fimmu.2018.01634","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser GP","year":"2006","unstructured":"Wormser GP, Dattwyler RJ, Shapiro ED, et al.. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006, 43:1089-134. 10.1086\/508667","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyi129","article-title":"Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms","volume":"34","author":"Cairns V","year":"2005","unstructured":"Cairns V, Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol. 2005, 34:1340-5. 10.1093\/ije\/dyi129","journal-title":"Int J Epidemiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.21775\/cimb.042.473","article-title":"Lyme disease pathogenesis","volume":"42","author":"Coburn J","year":"2021","unstructured":"Coburn J, Garcia B, Hu LT, Jewett MW, Kraiczy P, Norris SJ, Skare J. Lyme disease pathogenesis. Curr Issues Mol Biol. 2021, 42:473-518. 10.21775\/cimb.042.473","journal-title":"Curr Issues Mol Biol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1344862","article-title":"Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?","volume":"15","author":"Adler BL","year":"2024","unstructured":"Adler BL, Chung T, Rowe PC, Aucott J. Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?. Front Neurol. 2024, 15:1344862. 10.3389\/fneur.2024.1344862","journal-title":"Front Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170961","article-title":"MicroRNA and mRNA transcriptome profiling in primary human astrocytes infected with Borrelia burgdorferi","volume":"12","author":"Casselli T","year":"2017","unstructured":"Casselli T, Qureshi H, Peterson E, et al.. MicroRNA and mRNA transcriptome profiling in primary human astrocytes infected with Borrelia burgdorferi. PLoS One. 2017, 12:e0170961. 10.1371\/journal.pone.0170961","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/art.22131","article-title":"Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis","volume":"54","author":"Steere AC","year":"2006","unstructured":"Steere AC, Angelis SM. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum. 2006, 54:3079-86. 10.1002\/art.22131","journal-title":"Arthritis Rheum"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2017.06.002","article-title":"Doctor says you are cured, but you still feel the pain. Borrelia DNA persistence in Lyme disease","volume":"19","author":"Cervantes J","year":"2017","unstructured":"Cervantes J. Doctor says you are cured, but you still feel the pain. Borrelia DNA persistence in Lyme disease. Microbes Infect. 2017, 19:459-63. 10.1016\/j.micinf.2017.06.002","journal-title":"Microbes Infect"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00071-16","article-title":"CCL19 as a chemokine risk factor for posttreatment Lyme disease syndrome: a prospective clinical cohort study","volume":"23","author":"Aucott JN","year":"2016","unstructured":"Aucott JN, Soloski MJ, Rebman AW, et al.. CCL19 as a chemokine risk factor for posttreatment Lyme disease syndrome: a prospective clinical cohort study. Clin Vaccine Immunol. 2016, 23:757-66. 10.1128\/CVI.00071-16","journal-title":"Clin Vaccine Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11060789","article-title":"Lyme neuroborreliosis: mechanisms of B. burgdorferi infection of the nervous system","volume":"11","author":"Ford L","year":"2021","unstructured":"Ford L, Tufts DM. Lyme neuroborreliosis: mechanisms of B. burgdorferi infection of the nervous system. Brain Sci. 2021, 11:789. 10.3390\/brainsci11060789","journal-title":"Brain Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/art.39866","article-title":"Autoimmune arthritides, rheumatoid arthritis, psoriatic arthritis, or peripheral spondyloarthritis following Lyme disease","volume":"69","author":"Arvikar SL","year":"2017","unstructured":"Arvikar SL, Crowley JT, Sulka KB, Steere AC. Autoimmune arthritides, rheumatoid arthritis, psoriatic arthritis, or peripheral spondyloarthritis following Lyme disease. Arthritis Rheumatol. 2017, 69:194-202. 10.1002\/art.39866","journal-title":"Arthritis Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18648","article-title":"Lyme borreliosis as a trigger for autoimmune disease","volume":"13","author":"Yehudina Y","year":"2021","unstructured":"Yehudina Y, Trypilka S. Lyme borreliosis as a trigger for autoimmune disease. Cureus. 2021, 13:e18648. 10.7759\/cureus.18648","journal-title":"Cureus"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2010.03.002","article-title":"Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms","volume":"24","author":"Chandra A","year":"2010","unstructured":"Chandra A, Wormser GP, Klempner MS, Trevino RP, Crow MK, Latov N, Alaedini A. Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun. 2010, 24:1018-24. 10.1016\/j.bbi.2010.03.002","journal-title":"Brain Behav Immun"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI58813","article-title":"Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy","volume":"122","author":"Bockenstedt LK","year":"2012","unstructured":"Bockenstedt LK, Gonzalez DG, Haberman AM, Belperron AA. Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy. J Clin Invest. 2012, 122:2652-60. 10.1172\/JCI58813","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01050-07","article-title":"Persistence of Borrelia burgdorferi following antibiotic treatment in mice","volume":"52","author":"Hodzic E","year":"2008","unstructured":"Hodzic E, Feng S, Holden K, Freet KJ, Barthold SW. Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother. 2008, 52:1728-36. 10.1128\/AAC.01050-07","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780361118","article-title":"Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis","volume":"36","author":"H\u00e4upl T","year":"1993","unstructured":"H\u00e4upl T, Hahn G, Rittig M, et al.. Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis. Arthritis Rheum. 1993, 36:1621-6. 10.1002\/art.1780361118","journal-title":"Arthritis Rheum"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/ard.57.2.118","article-title":"Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy","volume":"57","author":"Priem S","year":"1998","unstructured":"Priem S, Burmester GR, Kamradt T, Wolbart K, Rittig MG, Krause A. Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Ann Rheum Dis. 1998, 57:118-21. 10.1136\/ard.57.2.118","journal-title":"Ann Rheum Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12061021","article-title":"Complete remission in paralytic late tick-borne neurological disease comprising mixed involvement of Borrelia, Babesia, Anaplasma, and Bartonella: use of long-term treatments with antibiotics and antiparasitics in a series of 10 cases","volume":"12","author":"Trouillas P","year":"2023","unstructured":"Trouillas P, Franck M. Complete remission in paralytic late tick-borne neurological disease comprising mixed involvement of Borrelia, Babesia, Anaplasma, and Bartonella: use of long-term treatments with antibiotics and antiparasitics in a series of 10 cases. Antibiotics (Basel). 2023, 12:1021. 10.3390\/antibiotics12061021","journal-title":"Antibiotics (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2174\/1874205X01206010158","article-title":"Chronic Lyme disease and co-infections: differential diagnosis","volume":"6","author":"Berghoff W","year":"2012","unstructured":"Berghoff W. Chronic Lyme disease and co-infections: differential diagnosis. Open Neurol J. 2012, 6:158-78. 10.2174\/1874205X01206010158","journal-title":"Open Neurol J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group","volume":"121","author":"Fukuda K","year":"1994","unstructured":"Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994, 121:953-9. 10.7326\/0003-4819-121-12-199412150-00009","journal-title":"Ann Intern Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1515\/sjpain-2018-0095","article-title":"Pain is associated with reduced quality of life and functional status in patients with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"19","author":"Strand EB","year":"2019","unstructured":"Strand EB, Mengshoel AM, Sandvik L, Helland IB, Abraham S, Nes LS. Pain is associated with reduced quality of life and functional status in patients with myalgic encephalomyelitis\/chronic fatigue syndrome. Scand J Pain. 2019, 19:61-72. 10.1515\/sjpain-2018-0095","journal-title":"Scand J Pain"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1080\/21641846.2020.1778227","article-title":"Post-viral fatigue and COVID-19: lessons from past epidemics","volume":"8","author":"Islam MF","year":"2020","unstructured":"Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fat Biomed Health Behav. 2020, 8:61-9. 10.1080\/21641846.2020.1778227","journal-title":"Fat Biomed Health Behav"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113202","article-title":"Chronic active Epstein-Barr virus infection: is it immunodeficiency, malignancy, or both?","volume":"12","author":"Fujiwara S","year":"2020","unstructured":"Fujiwara S, Nakamura H. Chronic active Epstein-Barr virus infection: is it immunodeficiency, malignancy, or both?. Cancers (Basel). 2020, 12:3202. 10.3390\/cancers12113202","journal-title":"Cancers (Basel)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192262","article-title":"Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection","volume":"217","author":"Fournier B","year":"2020","unstructured":"Fournier B, Boutboul D, Bruneau J, et al.. Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection. J Exp Med. 2020, 217:e20192262. 10.1084\/jem.20192262","journal-title":"J Exp Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/260849-what-makes-it-tick-exploring-the-mechanisms-of-post-treatment-lyme-disease-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T13:25:50Z","timestamp":1721481950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/260849-what-makes-it-tick-exploring-the-mechanisms-of-post-treatment-lyme-disease-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,20]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.64987","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,20]]}}}